Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
198.4
USD
|
+0.03%
|
|
-1.53%
|
-12.71%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
16,426
|
19,826
|
30,070
|
20,864
|
19,297
|
16,725
|
-
|
-
|
Enterprise Value (EV)
1 |
22,393
|
24,301
|
34,110
|
25,774
|
23,815
|
21,542
|
20,704
|
20,316
|
P/E ratio
|
20.3
x
|
12.8
x
|
12.9
x
|
16.9
x
|
47.6
x
|
17.1
x
|
15.2
x
|
13.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
1.44%
|
1.48%
|
1.51%
|
Capitalization / Revenue
|
1.42
x
|
1.42
x
|
1.87
x
|
1.4
x
|
1.59
x
|
1.31
x
|
1.25
x
|
1.19
x
|
EV / Revenue
|
1.94
x
|
1.74
x
|
2.12
x
|
1.73
x
|
1.96
x
|
1.68
x
|
1.54
x
|
1.45
x
|
EV / EBITDA
|
11
x
|
6.6
x
|
8.11
x
|
8.82
x
|
11.5
x
|
9.75
x
|
8.8
x
|
8.16
x
|
EV / FCF
|
21.4
x
|
13.9
x
|
12.9
x
|
17.5
x
|
27.2
x
|
20.1
x
|
15.7
x
|
13.5
x
|
FCF Yield
|
4.66%
|
7.22%
|
7.77%
|
5.72%
|
3.67%
|
4.98%
|
6.38%
|
7.39%
|
Price to Book
|
2.17
x
|
2.12
x
|
2.85
x
|
2.06
x
|
2.42
x
|
2.04
x
|
1.84
x
|
1.69
x
|
Nbr of stocks (in thousands)
|
97,100
|
97,400
|
95,700
|
88,600
|
84,900
|
84,300
|
-
|
-
|
Reference price
2 |
169.2
|
203.6
|
314.2
|
235.5
|
227.3
|
198.4
|
198.4
|
198.4
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/10/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,555
|
13,978
|
16,121
|
14,877
|
12,162
|
12,802
|
13,426
|
14,059
|
EBITDA
1 |
2,045
|
3,681
|
4,207
|
2,924
|
2,072
|
2,209
|
2,352
|
2,491
|
EBIT
1 |
1,711
|
3,332
|
3,831
|
2,549
|
1,715
|
1,833
|
1,962
|
2,121
|
Operating Margin
|
14.81%
|
23.84%
|
23.76%
|
17.13%
|
14.1%
|
14.32%
|
14.61%
|
15.08%
|
Earnings before Tax (EBT)
1 |
1,105
|
2,219
|
3,127
|
1,583
|
568.9
|
1,370
|
1,506
|
1,595
|
Net income
1 |
823.8
|
1,556
|
2,377
|
1,279
|
418
|
981.6
|
1,110
|
1,213
|
Net margin
|
7.13%
|
11.13%
|
14.75%
|
8.6%
|
3.44%
|
7.67%
|
8.27%
|
8.62%
|
EPS
2 |
8.350
|
15.88
|
24.39
|
13.97
|
4.770
|
11.61
|
13.09
|
14.56
|
Free Cash Flow
1 |
1,044
|
1,754
|
2,649
|
1,474
|
874.1
|
1,073
|
1,321
|
1,501
|
FCF margin
|
9.04%
|
12.54%
|
16.43%
|
9.91%
|
7.19%
|
8.38%
|
9.84%
|
10.68%
|
FCF Conversion (EBITDA)
|
51.08%
|
47.64%
|
62.98%
|
50.42%
|
42.18%
|
48.57%
|
56.19%
|
60.28%
|
FCF Conversion (Net income)
|
126.79%
|
112.69%
|
111.44%
|
115.24%
|
209.11%
|
109.31%
|
119.02%
|
123.81%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
2.852
|
2.932
|
2.987
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/10/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
4,060
|
4,056
|
3,900
|
3,697
|
3,606
|
3,674
|
3,778
|
3,034
|
3,057
|
3,033
|
3,177
|
3,190
|
3,232
|
3,234
|
3,367
|
EBITDA
1 |
1,001
|
997.3
|
888.4
|
748.8
|
681
|
605.5
|
590.1
|
539.6
|
514.1
|
482.1
|
547.2
|
562.3
|
565.1
|
550.6
|
584
|
EBIT
1 |
907.1
|
902.2
|
794
|
656.1
|
589.1
|
509.9
|
493.5
|
448.3
|
423.9
|
394.9
|
452.8
|
465.7
|
464.5
|
450.4
|
486.9
|
Operating Margin
|
22.34%
|
22.24%
|
20.36%
|
17.75%
|
16.34%
|
13.88%
|
13.06%
|
14.78%
|
13.87%
|
13.02%
|
14.25%
|
14.6%
|
14.37%
|
13.92%
|
14.46%
|
Earnings before Tax (EBT)
1 |
768.2
|
686
|
640.1
|
476.4
|
421.6
|
44.5
|
277.8
|
205
|
238.7
|
-147.1
|
297.4
|
344.6
|
350.1
|
320.5
|
378.5
|
Net income
1 |
587.3
|
553
|
491.6
|
358.6
|
352.8
|
76.1
|
212.9
|
188.9
|
183.3
|
-167.1
|
228
|
260.6
|
261.5
|
247.7
|
273.7
|
Net margin
|
14.47%
|
13.63%
|
12.61%
|
9.7%
|
9.78%
|
2.07%
|
5.64%
|
6.23%
|
6%
|
-5.51%
|
7.18%
|
8.17%
|
8.09%
|
7.66%
|
8.13%
|
EPS
2 |
6.050
|
5.750
|
5.230
|
3.870
|
3.900
|
0.8600
|
2.390
|
2.120
|
2.110
|
-1.970
|
2.690
|
3.023
|
2.981
|
2.868
|
3.240
|
Dividend per Share
2 |
-
|
-
|
-
|
0.7200
|
0.7200
|
-
|
0.7200
|
0.7200
|
-
|
-
|
0.7360
|
0.7360
|
0.7360
|
0.7360
|
0.7438
|
Announcement Date
|
10/28/21
|
2/10/22
|
4/28/22
|
7/28/22
|
10/27/22
|
2/16/23
|
4/25/23
|
7/27/23
|
10/26/23
|
2/15/24
|
4/25/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,967
|
4,475
|
4,040
|
4,910
|
4,518
|
4,817
|
3,979
|
3,591
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.918
x
|
1.216
x
|
0.9605
x
|
1.679
x
|
2.18
x
|
2.18
x
|
1.692
x
|
1.442
x
|
Free Cash Flow
1 |
1,045
|
1,754
|
2,649
|
1,474
|
874
|
1,073
|
1,321
|
1,501
|
ROE (net income / shareholders' equity)
|
15.4%
|
27.7%
|
28.2%
|
17.9%
|
13.2%
|
15.3%
|
15.7%
|
15.8%
|
ROA (Net income/ Total Assets)
|
6.53%
|
12.3%
|
11%
|
4.5%
|
6.44%
|
6.85%
|
7.29%
|
7.79%
|
Assets
1 |
12,619
|
12,641
|
21,571
|
28,397
|
6,490
|
14,329
|
15,234
|
15,573
|
Book Value Per Share
2 |
77.80
|
96.00
|
110.0
|
114.0
|
93.90
|
97.30
|
108.0
|
117.0
|
Cash Flow per Share
2 |
14.70
|
21.80
|
31.90
|
21.40
|
15.20
|
18.20
|
20.50
|
23.30
|
Capex
1 |
400
|
382
|
460
|
482
|
454
|
461
|
463
|
499
|
Capex / Sales
|
3.46%
|
2.73%
|
2.86%
|
3.24%
|
3.73%
|
3.6%
|
3.45%
|
3.55%
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/10/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
198.4
USD Average target price
239.1
USD Spread / Average Target +20.50% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.71% | 16.73B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B | | -3.97% | 11.66B |
Other Healthcare Facilities & Services
|